This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
September 22-25, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Keenan Bashour
VP, Manufacturing & Process Development at 4D Molecular Therapeutics
Speaker

Profile

Keenan Bashour is the VP of Manufacturing and Process Development at 4D Molecular Therapeutics, where his team develops scalable platforms and oversees the manufacturing of custom adeno-associated virus (AAV) serotypes. Prior to his time at 4D Molecular Therapeutics, Keenan developed manufacturing processes for allogeneic and autologous cell therapies at Allogene Therapeutics and Juno Therapeutics (now Bristol-Meyers Squibb).

Agenda Sessions

  • Keynote Panel Discussion: Strategies for Scaling Up, Accelerating and Commercializing Gene Therapy Manufacturing

    , 9:00am
    View Session

At this event

Prev
Next
Todd McDevitt
Vice President, Head of Cell Therapy
Genentech, A Member of the Roche Group

See Keenan at Cell & Gene Therapy International

Book Now